Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 845

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 845
---
 The New Plan allows non -marketableoptions (hereinafter, the “Options”) that can be exercised for the Company’s shares to be granted at different exercise prices, as well as restricted share units. The New Plan entered into force on the day of its adoption by the Board of Directors, subject to the required submission to the tax authorities, in accordance with the law. The New Plan will expire at the end of 10 years from the aforementioned date. C.On March 10, 2021, the general meeting of the shareholders approved the grant of Options to the Company’s former Chief Executive Officer (the “CEO”) as part of his employment agreement, as well as to the current chairman of the Company’s Board of Directors as part of the engagement agreement, according to which 500,000 Options were granted to the Company’s CEO, each of which is exercisable into one Share. The exercise price of the Options will be as follows: 300,000 options at an exercise price of USD $0.7 (NIS 2.3), 150,000 options at an exercise price of USD $1 (NIS 3), and 50,000 options at an exercise price of USD $1.7 (NIS 5). The vesting period of the Options is three years, wherein one -thirdof the Options are to mature after 1 year and the remaining Options are to mature linearly over eight quarters. The Options were granted in the equity track under section 102 under the Company’s standard conditions and in accordance with the Company’s option plan. The Options will be exercisable for a period of 5 years from their grant date. The CEO’s Options’ value of USD $62 thousand was determined according to the Black -Scholesmodel based on the following assumptions: 100,000 options were granted to the chairman of the Board of Directors, each of which is exercisable into one Share for an exercise price of USD $0.81 (NIS 2.68). The vesting period of the Options is one year from their grant date. The Options will be exercisable for a period of five years from their grant date. The Options were granted in the equity track under section 102 under the Company’s standard conditions and in accordance with the Company’s option plan. The chairman of the Board of Directors’ Options’ value of USD $30 thousand was determined according to the Black -Scholesmodel based on the following assumptions:

| Dividend yield for the share (%)